Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Biogen Idec
Biogen Idec
Grading Pharma In 2013: 16 Drug Companies Ranked
Forbes
Tue, 12/31/13 - 10:17 am
Bristol-Myers Squibb
Celgene
Gilead Sciences
Biogen Idec
AbbVie
Roche
JNJ
GSK
Amgen
Novo Nordisk
Pfizer
Novartis
Merck
Sanofi
AstraZeneca
Eli Lilly
Jim Cramer: Ride the Four Horsemen of Biotech
TheStreet.com
Fri, 12/27/13 - 09:34 am
biotech
Biogen Idec
Celgene
Gilead Sciences
Regeneron
Biogen's Biosimilars Vs. Amgen, Johnson & Johnson
Seeking Alpha
Mon, 12/23/13 - 10:01 am
Amgen
Biogen Idec
biosimilars
JNJ
Samsung Bioepis
Celltrion
Hospira
Remsima
Inflectra
Keep an Eye on Biogen, Johnson & Johnson, and Merck Today
Motley Fool
Tue, 12/17/13 - 10:42 am
Biogen Idec
JNJ
Merck
Bravecto
animal health
Samsung
Hospira
Amgen
AbbVie
anti-TNF
Biogen Idec preps for a big leap into the anti-TNF blockbuster biosimilars market
Fierce Biotech
Tue, 12/17/13 - 09:39 am
Biogen Idec
anti-TNF
Samsung Bioepis
Samsung
biosimilars
Better Earnings: Celgene, Biogen, Or Amgen?
Motley Fool
Fri, 12/6/13 - 08:58 am
Celgene
Biogen Idec
earnings
Amgen
Biogen Idec says FDA will allow 3 more months to review its hemophilia B drug Alprolix
Yahoo/AP
Mon, 12/2/13 - 10:15 am
Biogen Idec
FDA
hemophilia B
Alprolix
2014 FDA Drug Approval Decision Calendar
TheStreet.com
Wed, 11/27/13 - 08:39 am
FDA
drug approvals
GSK
Gilead
Theravance
Auxilium
Amarin
Bristol-Myers Squibb
Biogen Idec
Pozen
Vanda
Chelsea Therapeutics
pSivida
Alimera
United Therapeutics
Biomarin
JNJ
Pharmacyclics
Celgene
MannKind
Santarus
AstraZeneca
Durata Therapeutics
Eli Lilly
Omeros
BioDelivery Sciences
Anacor
Keryx
Cubist Pharmaceuticals
Nektar
Biogen's Tecfidera Time-Out Pays Off
Motley Fool
Tue, 11/26/13 - 04:38 pm
Tecfidera
Biogen Idec
MS
multiple sclerosis
4 Biotech Stocks Making Big Moves
Wall St Cheat Sheet
Sun, 11/24/13 - 12:20 pm
Athersys
Pfizer
Biogen Idec
Neuralstem
Pozen
The Four Horseman of Pharma
CNBC
Sat, 11/23/13 - 12:36 pm
Gilead
Biogen Idec
Celgene
Regeneron
Biogen wins protection for MS drug Tecfidera in Europe
Yahoo/Reuters
Fri, 11/22/13 - 09:01 am
Biogen Idec
MS
multiple sclerosis
Europe
Tecfidera
Biogen Idec 5-Year Revenue Outlook
Seeking Alpha
Tue, 11/19/13 - 07:24 am
Biogen Idec
Biogen’s Hemophilia Drug Delay May Push Sales to Mid-2014
Bloomberg
Tue, 11/12/13 - 01:09 pm
hemophilia
Biogen Idec
Eloctate
Isis Pharmaceuticals earns $1.5M milestone payment from Biogen Idec
The Fly on the Wall
Tue, 11/12/13 - 07:58 am
Isis Pharmaceuticals
Biogen Idec
spinal muscular atrophy
ISIS-SMNRx
Tecfidera Succeeds in Protecting Biogen's MS Market Share From Novartis' Gilenya
Motley Fool
Sun, 11/3/13 - 12:12 pm
Gilenya
Novartis
MS
multiple sclerosis
Biogen Idec
Tecfidera
Biogen's new MS drug tops sales expectations, earnings rise
Yahoo/Reuters
Mon, 10/28/13 - 08:35 am
Biogen Idec
earnings
Biogen MS Drug Rollout Eyed Ahead Of Q3 Earnings
investors.com
Sat, 10/26/13 - 10:49 am
Biogen Idec
MS
multiple sclerosis
Biotech Stock Bubble Debate in 14 Charts
TheStreet.com
Wed, 10/23/13 - 08:32 am
biotech
Bluebird Bio
Celgene
Celldex
Onconova
Aegerion
Receptos
Immunomedics
Alcobra
Gilead
Biogen Idec
Ambit Biosciences
Catalyst Pharmaceuticals And Their Business Plan
Seeking Alpha
Mon, 10/21/13 - 11:51 am
Catalyst Pharmaceutical Partners
Biomarin
Biogen Idec
Firdapse
Lambert-Eaton myasthenic syndrome
Pages
« first
‹ previous
…
4
5
6
7
8
9
10
11
12
…
next ›
last »